Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jan 6, 2026
Reporting period
Not applicable
Filed with the SEC
Jan 9, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001213900-26-002659
Filed / recorded
Jan 9, 2026, 2:27 AM UTC
Added to OQRO
Oct 8, 2026, 2:41 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Health In Tech, Inc.
Issuer CIK
2019505
Ticker
HIT
Reporting person
Tim Donald Johnson
Relationship
Director, Officer, 10% owner
Officer title
Chief Executive Officer
Security
Class A Common Stock
Table
Non-derivative (Table I)
Transaction date
Jan 6, 2026
Transaction code
A
Shares / units
1,000,000
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
23,549,741
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan in connection with two proposed issuer transactions (each, a "Transaction"). Half of the shares vest in equal monthly installments over 12 months starting at the closing of the first Transaction ("First Transaction Shares"). The other half vest in equal monthly installments over 12 months starting at the closing of the second Transaction ("Second Transaction Shares"). Vesting is subject to continued service. If either Transaction does not close within 24 months after January 6, 2026 (the "Grant Date"), unvested shares relating to that Transaction will be automatically forfeited without consideration.
Includes 1,126,130 shares of restricted shares of Class A Common Stock and 22,423,611 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.